Fit-for-purpose biomarker testing services with an extensive menu of 500+ biomarkers
Biomarker analysis services
Biomarker-driven drug development approaches are widely used and have the potential to make drug discovery, development, and approval processes more efficient while improving patient outcomes. The data derived from biomarkers plays a key role in decision-making throughout the entire drug development pipeline, from drug mode of action, efficacy and safety assessments, to patient stratification and evaluation of clinical trial endpoints.
Mercodia offers comprehensive biomarker testing solutions, including large molecules, biosimilars, peptides, and oligonucleotides to support pharmaceutical and biotechnology companies in drug development. Understanding the specific context of use of a biomarker is essential for designing a cost- and time-effective bioanalytical strategy. Learn how to tailor your bioanalytical strategy to fit the study needs
Explore our 500+ biomarkers and panels in the Biomarker Menu or the Assay Menu for a selection of human assays. We are continuously expanding our portfolio to enable healthcare providers, researchers, and clinicians to address a wide range of clinical and research questions. If you cannot find the marker you are looking for, contact us and we will provide you with a solution.